Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of placental, fetal brain and renal outcomes of IUGR
Mechanisms Of HIV-1 Induced Cell Death and Latency Formation in CD4+ Lymphocytes
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis
Molecular Markers of Glioma Initiation and Progression
Structural and Functional Studies of Mammalian Endogenous Retroviral Sequences
Recently added grants:
Antifungal Liposomes Targeted to Cell Wall Mannans
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
Mentoring Investigators in HIV and Tuberculosis Therapeutics Research
Redefining Mycobacterium tuberculosis genes essential for infection
Anaplasma phagocytophilum modulates the type IV secretion system pilus to achieve tick transmission
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM62201-5-0-2
Application #
7568588
Study Section
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Early Therapeutics Development with Phase II Emphasis
/ University of Chicago
$662,981
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
Vokes, Everett E. /
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
Comments
Be the first to comment on this grant